61 related articles for article (PubMed ID: 11445115)
1. Potential specific breast cancer treatment uncovered in mouse experiments.
Bradbury J
Lancet; 2001 Jun; 357(9274):2109. PubMed ID: 11445115
[No Abstract] [Full Text] [Related]
2. Requirement for CDK4 kinase function in breast cancer.
Yu Q; Sicinska E; Geng Y; Ahnström M; Zagozdzon A; Kong Y; Gardner H; Kiyokawa H; Harris LN; Stål O; Sicinski P
Cancer Cell; 2006 Jan; 9(1):23-32. PubMed ID: 16413469
[TBL] [Abstract][Full Text] [Related]
3. Specific protection against breast cancers by cyclin D1 ablation.
Yu Q; Geng Y; Sicinski P
Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 in breast cancer pathogenesis.
Arnold A; Papanikolaou A
J Clin Oncol; 2005 Jun; 23(18):4215-24. PubMed ID: 15961768
[TBL] [Abstract][Full Text] [Related]
5. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV
Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859
[TBL] [Abstract][Full Text] [Related]
6. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 genotype and breast cancer metastasis.
Langsenlehner U; Hofmann G; Samonigg H; Krippl P; Renner W; Clar H
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1844-5. PubMed ID: 16030129
[No Abstract] [Full Text] [Related]
8. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile.
Mottolese M; Orlandi G; Sperduti I; Merola R; Buglioni S; Di Benedetto A; Pinnarò P; Perracchio L; Venturo I; Cognetti F; Cianciulli A
Am J Surg Pathol; 2007 Feb; 31(2):247-54. PubMed ID: 17255770
[TBL] [Abstract][Full Text] [Related]
9. Examining the role of cyclin D1 in breast cancer.
Velasco-Velázquez MA; Li Z; Casimiro M; Loro E; Homsi N; Pestell RG
Future Oncol; 2011 Jun; 7(6):753-65. PubMed ID: 21675838
[TBL] [Abstract][Full Text] [Related]
10. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.
Aaltonen K; Amini RM; Landberg G; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H; Blomqvist C
Breast Cancer Res Treat; 2009 Jan; 113(1):75-82. PubMed ID: 18240019
[TBL] [Abstract][Full Text] [Related]
12. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
13. Are all cancer genes equal?
Bartek J; Lukas J
Nature; 2001 Jun; 411(6841):1001-2. PubMed ID: 11429580
[No Abstract] [Full Text] [Related]
14. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells.
Joung YH; Lim EJ; Lee MY; Park JH; Ye SK; Park EU; Kim SY; Zhang Z; Lee KJ; Park DK; Park T; Moon WK; Yang YM
Exp Mol Med; 2005 Aug; 37(4):353-64. PubMed ID: 16155412
[TBL] [Abstract][Full Text] [Related]
16. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
[TBL] [Abstract][Full Text] [Related]
17. Edging toward new therapeutics with cyclin D1 Egl'ng on cancer.
Dang CV
Cancer Cell; 2009 Nov; 16(5):361-2. PubMed ID: 19878865
[TBL] [Abstract][Full Text] [Related]
18. [Regulatory proteins of the cell cycle: alterations in the cycline D1 pathway as a paradigm. Findings in breast cancer].
Eres N; Bellmunt J
Med Clin (Barc); 1998 Nov; 111(15):592-6. PubMed ID: 9859095
[No Abstract] [Full Text] [Related]
19. [Cyclin D1 and breast cancer: the good news of summer 2001].
Larsen CJ
Bull Cancer; 2001 Aug; 88(8):717-8. PubMed ID: 11578938
[No Abstract] [Full Text] [Related]
20. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
